ABBVIE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- $346B
- Website
- http://www.abbvie.com
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer
- First Posted Date
- 2010-03-11
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 35
- Registration Number
- NCT01085422
Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine
Completed
- Conditions
- Crohn's Disease
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 4107
- Registration Number
- NCT01083680
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice
Completed
- Conditions
- Kidney InsufficiencySecondary Hyperparathyroidism
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 761
- Registration Number
- NCT01083849
- Locations
- 🇦🇹
Site Reference ID/Investigator# 64523, Rottenmann, Austria
🇩🇪Site Reference ID/Investigator# 48865, Hanover, Germany
🇩🇪Site Reference ID/Investigator# 28019, Herzberg, Germany
Surveillance of Kaletra in Korean Patients
Completed
- Conditions
- HIV-1 Infection
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 595
- Registration Number
- NCT01083173
Surveillance of Humira Injection in Korean Patients
Completed
- Conditions
- Rheumatoid ArthritisPsoriatic ArthritisAnkylosing SpondylitisCrohn's DiseasePsoriasis
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 1779
- Registration Number
- NCT01083121
- Locations
- 🇰🇷
Site Reference ID/Investigator# 66654, Seoul, Korea, Republic of
🇰🇷Site Reference ID/Investigator# 63322, Seoul, Korea, Republic of
🇰🇷Site Reference ID/Investigator# 29748, Seoul, Korea, Republic of
Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience
Completed
- Conditions
- Chronic Kidney FailureSecondary Hyperparathyroidism
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2013-03-12
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 500
- Registration Number
- NCT01083186
- Locations
- 🇬🇷
Site Reference ID/Investigator# 27498, Haidari, Athens, Greece
🇬🇷Site Reference ID/Investigator# 27495, Athens, Greece
🇬🇷Site Reference ID/Investigator# 43773, Athens, Greece
Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)
Completed
- Conditions
- Ankylosing Spondylitis
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2015-07-09
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 4681
- Registration Number
- NCT01079182
A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2013-08-20
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 35
- Registration Number
- NCT01078597
- Locations
- 🇮🇪
Site Reference ID/Investigator# 49403, Cork, Ireland
🇮🇪Site Reference ID/Investigator# 49402, Cork, Ireland
🇮🇪Site Reference ID/Investigator# 22307, Dublin 24, Ireland
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis
Completed
- Conditions
- Rheumatoid ArthritisOsteoporosis
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 131
- Registration Number
- NCT01078155
EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
Completed
- Conditions
- Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsARheumatoid Arthritis (RA
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 809
- Registration Number
- NCT01078402
- Locations
- 🇭🇷
Site Reference ID/Investigator# 43284, Split, Croatia
🇭🇷Site Reference ID/Investigator# 22405, Zagreb, Croatia
🇭🇺Site Reference ID/Investigator# 32641, Budapest, Hungary
© Copyright 2025. All Rights Reserved by MedPath